Skip to content
Baret News – Lifestyle
Author:
Pet ‘n Shape
Milestone Pharmaceuticals Initiates Pivotal Phase 3 Trial of Etripamil Nasal Spray for Self-Administered Treatment of Atrial Fibrillation with Rapid Ventricular Rate (AFib-RVR)
August 21, 2026
Milestone Pharmaceuticals Announces Second Quarter 2026 Financial Results and Provides Corporate Update
August 12, 2026
Pet ‘n Shape® Unveils New Packaging to Celebrate 20 Years of Trusted Treats
April 28, 2026